|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM277298180 |
003 |
DE-627 |
005 |
20250222121657.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2018 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/j.clim.2017.10.008
|2 doi
|
028 |
5 |
2 |
|a pubmed25n0924.xml
|
035 |
|
|
|a (DE-627)NLM277298180
|
035 |
|
|
|a (NLM)29061446
|
035 |
|
|
|a (PII)S1521-6616(17)30641-1
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Ishioka-Takei, Eriko
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Increased proportion of a CD38highIgD+ B cell subset in peripheral blood is associated with clinical and immunological features in patients with primary Sjögren's syndrome
|
264 |
|
1 |
|c 2018
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 18.03.2019
|
500 |
|
|
|a Date Revised 18.03.2019
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Copyright © 2017 Elsevier Inc. All rights reserved.
|
520 |
|
|
|a We investigated the correlation between the increased proportion of peripheral B cell subsets and clinical and immunological features in primary Sjögren's syndrome (pSS). We found that the proportion of CD19+ B cells was significantly increased in pSS as compared with HC and was correlated with serum IgG levels. Moreover, in vitro IgG production by CD19+ B cells was significantly increased in pSS and was positively and significantly correlated with serum IgG levels. FACS analysis revealed that the proportions of peripherally CD38highIgD+ B cells and CD38highIgD- B cells were significantly increased in pSS. In addition, the proportion of CD38highIgD+ B cells positively correlated with ESSDAI scores and serum levels of IgG, anti-Ro/SSA and anti-La/SSB antibodies while that of CD38highIgD- B cells showed no correlation with these parameters. Our data suggest that increased proportion of CD38highIgD+ B cells in pSS is involved in IgG overproduction including autoantibodies, and correlates with disease progression
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
4 |
|a Autoantibodies
|
650 |
|
4 |
|a B cell
|
650 |
|
4 |
|a CD38
|
650 |
|
4 |
|a ESSDAI
|
650 |
|
4 |
|a IgD
|
650 |
|
4 |
|a IgG
|
650 |
|
4 |
|a Sjögren's syndrome
|
650 |
|
7 |
|a Antibodies, Antinuclear
|2 NLM
|
650 |
|
7 |
|a Antigens, CD19
|2 NLM
|
650 |
|
7 |
|a Immunoglobulin D
|2 NLM
|
650 |
|
7 |
|a Immunoglobulin G
|2 NLM
|
650 |
|
7 |
|a SS-A antibodies
|2 NLM
|
650 |
|
7 |
|a SS-B antibodies
|2 NLM
|
650 |
|
7 |
|a ADP-ribosyl Cyclase 1
|2 NLM
|
650 |
|
7 |
|a EC 3.2.2.6
|2 NLM
|
700 |
1 |
|
|a Yoshimoto, Keiko
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Suzuki, Katsuya
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Nishikawa, Ayumi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Yasuoka, Hidekata
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Yamaoka, Kunihiro
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Takeuchi, Tsutomu
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 187(2018) vom: 01. Feb., Seite 85-91
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
773 |
1 |
8 |
|g volume:187
|g year:2018
|g day:01
|g month:02
|g pages:85-91
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2017.10.008
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_11
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 187
|j 2018
|b 01
|c 02
|h 85-91
|